MKC vs. CVS
Compare and contrast key facts about McCormick & Company, Incorporated (MKC) and CVS Health Corporation (CVS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MKC or CVS.
Key characteristics
| MKC | CVS | |
|---|---|---|
| YTD Return | 11.30% | -13.32% |
| 1Y Return | -11.40% | -4.74% |
| 3Y Return (Ann) | -3.75% | -0.90% |
| 5Y Return (Ann) | 1.54% | 7.75% |
| 10Y Return (Ann) | 9.78% | 1.67% |
| Sharpe Ratio | -0.36 | -0.15 |
| Daily Std Dev | 24.42% | 25.37% |
| Max Drawdown | -41.18% | -64.07% |
| Current Drawdown | -24.33% | -35.16% |
Fundamentals
| MKC | CVS | |
|---|---|---|
| Market Cap | $20.32B | $84.68B |
| EPS | $2.62 | $6.47 |
| PE Ratio | 28.90 | 10.38 |
| PEG Ratio | 2.48 | 1.00 |
| Revenue (TTM) | $6.70B | $356.62B |
| Gross Profit (TTM) | $2.27B | $53.46B |
| EBITDA (TTM) | $1.22B | $18.44B |
Correlation
The correlation between MKC and CVS is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MKC vs. CVS - Performance Comparison
In the year-to-date period, MKC achieves a 11.30% return, which is significantly higher than CVS's -13.32% return. Over the past 10 years, MKC has outperformed CVS with an annualized return of 9.78%, while CVS has yielded a comparatively lower 1.67% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MKC vs. CVS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for McCormick & Company, Incorporated (MKC) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MKC vs. CVS - Dividend Comparison
MKC's dividend yield for the trailing twelve months is around 2.14%, less than CVS's 3.78% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MKC McCormick & Company, Incorporated | 2.14% | 2.32% | 1.81% | 1.44% | 1.33% | 1.37% | 1.53% | 1.89% | 1.89% | 1.91% | 2.03% | 2.02% |
CVS CVS Health Corporation | 3.78% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% | 1.14% | 1.26% |
Drawdowns
MKC vs. CVS - Drawdown Comparison
The maximum MKC drawdown since its inception was -41.18%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for MKC and CVS. For additional features, visit the drawdowns tool.
Volatility
MKC vs. CVS - Volatility Comparison
The current volatility for McCormick & Company, Incorporated (MKC) is 5.54%, while CVS Health Corporation (CVS) has a volatility of 8.80%. This indicates that MKC experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MKC vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between McCormick & Company, Incorporated and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities